Navigation section
covaxin
BHU study on side effects of Covaxin was poorly designed, ICMR mistakenly believed: Dr. Bahl
New Delhi: Indian Council of Medical Research Director General Dr Rajiv Bah on Monday criticized a recently published study on long-term safety analysis of Covaxin in adults and adolescents for poor methodology and design and termed the article as misleading and inaccurate. Did. "ICMR.Dr. Bahl...- NewsBot
- Article
- adolescents analysis bahl covaxin events given icmr long-term paper participants research safety study vaccine
- Category: National News
-
"Poor methodology," ICMR distances itself from Covaxin safety study, calls for withdrawal
New Delhi [India], Indian Council of Medical Research (ICMR) has distanced itself from a study published by Banaras Hindu University on Covaxin vaccine, citing serious methodological flaws and wrongful acceptance of ICMR's endorsement. The title of this study is "Long". -Term safety analysis of...- NewsBot
- Article
- asked bahl council covaxin developed director icmr icmr's indian medical published research safety study vaccine
- Category: National News
-
BHU study on side effects of Covaxin was poorly designed, ICMR admitted by mistake: Dr. Bahl
New Delhi: Indian Council of Medical Research Director General Dr Rajeev Bah on Monday criticized a recently published study on long-term safety analysis of Covaxin in adults and adolescents for poor methodology and design and termed the article as misleading and inaccurate. Did. "ICMR.Dr...- NewsBot
- Article
- adolescents adults analysis bahl covaxin events icmr long-term paper participants research safety study vaccine
- Category: National News
Covaxin shows excellent safety track record: Bharat Biotech quits study citing risks
The study led by Banaras Hindu University (BHU) claimed that Covaxin increases the risk of stroke and rare Guillain-Barré syndrome."Multiple studies have been conducted on the safety of Covaxin, and I have published it in peer-reviewed journals, demonstrating an excellent safety track record,"...- NewsBot
- Article
- 1 min read
- banaras claimed covaxin hindu increases profile rare risk safety stroke studies study subjects thrombocytopenia university
- Category: Technology & Innovation
Covaxin developed focusing on safety first: Bharat Biotech
New Delhi, Amid AstraZeneca's entry, Bharat Biotech on Thursday claimed that its Covid-19 vaccine Covaxy is safe and devoid of any side effects as Covishield can cause complications in rare cases.In a statement, the company said Covaxin was developed focusing on safety first, followed by...- NewsBot
- Article
- amid astrazeneca astrazeneca's bharat biotech cause covaxin covid-19 efficacy evaluated product rare safety thursday vaccine
- Category: Business & Economy
-
Bharat Biotech says Covaxin has excellent safety record
The Hyderabad-based company issued a statement amid questions being raised in some quarters over the safety of Covid vaccines after global drugmaker AstraZeneca admitted that its Covid vaccine Covishield, developed by researchers at the University of Oxford, may cause a blood clotting disorder...- NewsBot
- Article
- 1 min read
- astrazeneca bharat biotech blood cause covaxin covid covid-19 developed efficacy evaluated safety subjects vaccine vaccines
- Category: Business & Economy
-
"Safety is the primary focus for all our vaccines": Covaxin-developer Bharat Biotech amid reports on AstraZeneca vaccine
New Delhi [India], Amid reports of possible rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which has developed Covaxin, said in a statement that the vaccine will be developed "with a focus on safety first." "Together" will be developed. It said Covaxin was the...- NewsBot
- Article
- astrazeneca bharat biotech covaxin covid covid-19 covishield developed efficacy focus rare safety statement vaccine vaccines
- Category: National News